Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to $3 million.

The life-changing drug, developed by Boston-based Vertex and its Swiss partner CRISPR Therapeutics, targets sickle cell disease, an inherited blood disorder that causes crippling pain.

FDA approves first CRISPR therapy—here’s how it works against sickle cell The landmark treatment turns on another blood protein that prevents sickling.

A Shreveport-Bossier City musician is working tirelessly to better the quality of life for people like her sons, some of whom ae fighting a challenging disease.

A recent Vanderbilt study has found a cure for sickle cell disease, a blood disorder where the body creates mutated red blood cell proteins, which often leads to pain, anemia and other issues.

Pfizer believes a treatment for sickle cell disease and similar drugs in Global Blood Therapeutics’ pipeline could achieve combined worldwide sales of more than $3 billion, the company said in a ...

The team responsible for updating the CDC’s “contraception bible,” which advises doctors on birth control safety, was disbanded.

LONDON (AP) — Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the ...

The go-ahead for Vertex’s gene editing therapy in sickle cell disease and β-thalassemia is a historic milestone, but this one-time treatment is costly.

Alsheebani is one of the first adults in the world, and the first adult at the medical system, to be effectively cured of sickle cell disease using gene therapy.

NIH cancels research grant for disease that affects mostly Black patients, citing DEI, doctor says 90% of Sickle cell disease patients are Black, according to NIH ...